 WALTHAM, Mass., Sept. 21, 2021 PRNewswire -- CorEvitas, LLC, the gold-standard leader in longitudinal real-world data in autoimmune and inflammatory diseases, today announced that it has expanded its engagement with Inovalons NASDAQ: INOV life sciences business unit specializing in data-driven healthcare analytics and strategic advisory services, to provide a holistic view of patients with rheumatoid arthritis or psoriasis. 